Brief: Dr Ashleys Limited And Impact Biomedical Inc. Announce Strategic Merger
23/06/2025 12:52
June 23 (Reuters) - Impact Biomedical Inc IBO.A: DR ASHLEYS LIMITED AND IMPACT BIOMEDICAL INC. ANNOUNCE STRATEGIC MERGER IMPACT BIOMEDICAL INC - TO BE RENAMED 'DR ASHLEYS USA INC.' - SEC FILING IMPACT BIOMEDICAL INC - MERGER SUBJECT TO NYSE APPROVAL OF COMBINED COMPANY SHARES IMPACT BIOMEDICAL INC - DR ASHLEYS SHAREHOLDER TO RECEIVE 94.20% OF PUBCO SHARES - SEC FILING Further company coverage: IBO.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Impact Biomedical
See all newsBrief: Impact BioMedical Announces 1 For 12.62 Reverse Stock Split To Pursue Completion Of Merger With Zoar
Brief: Impact Biomedical Says On July 21 Entered Debt Conversion Agreement With DSS
Brief: Dr Ashleys Limited And Impact Biomedical Inc. Announce Strategic Merger
Brief: Impact BioMedical Announces Issuance Of Canadian Patent For Linebacker Technology Targeting Inflammatory Disease
Brief: Impact Biomedical Inc. Announces Pricing Of Initial Public Offering